TrialHepatology communications2024

Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites.

Rasmus H Gantzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.